A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
Authors
Keywords
Breast cancer, Estrogens, Hormones, Immunologic adjuvants, Metastasis, Multivariate analysis, Progesterone, Prognosis
Journal
PLoS One
Volume 12, Issue 2, Pages e0172031
Publisher
Public Library of Science (PLoS)
Online
2017-02-11
DOI
10.1371/journal.pone.0172031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A standardized method for quantifying proliferation by Ki-67 and cyclin A immunohistochemistry in breast cancer
- (2015) Kun Mu et al. Annals of Diagnostic Pathology
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Variability in Measuring the Ki-67 Labeling Index in Patients With Breast Cancer
- (2015) Shinya Yamamoto et al. Clinical Breast Cancer
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer
- (2015) Nobuyuki Arima et al. ONCOLOGY
- An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
- (2015) Ruohong Shui et al. PLoS One
- Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
- (2015) Zsuzsanna Varga et al. PLoS One
- Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
- (2014) Yu Zong et al. PLoS One
- Prognostic significance of the progesterone receptor status in Ki67-high and -low Luminal B-like HER2-negative breast cancers
- (2014) Kaolu Sato et al. Breast Cancer
- A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
- (2014) Jyothi S. Prabhu et al. Journal of Cancer
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information
- (2013) Linda P Feeley et al. MODERN PATHOLOGY
- Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy
- (2013) Naoko Honma et al. Breast Cancer
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
- (2012) G. Cancello et al. ANNALS OF ONCOLOGY
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now